Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases

Phillip A. Bonney, Joshua A. Santucci, Adrian J. Maurer, Michael E. Sughrue, Rene Y. McNall-Knapp, James D. Battiste

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases'. Together they form a unique fingerprint.

Medicine & Life Sciences